Next Article in Journal
STING Agonists as Cancer Therapeutics
Next Article in Special Issue
A Collaborative Model to Implement Flexible, Accessible and Efficient Oncogenetic Services for Hereditary Breast and Ovarian Cancer: The C-MOnGene Study
Previous Article in Journal
Involvement of Thyroid Hormones in Brain Development and Cancer
Previous Article in Special Issue
BRCA Genetic Test and Risk-Reducing Salpingo-Oophorectomy for Hereditary Breast and Ovarian Cancer: State-of-the-Art
 
 
Brief Report

Article Versions Notes

Cancers 2021, 13(11), 2694; https://doi.org/10.3390/cancers13112694
Action Date Notes Link
article xml file uploaded 30 May 2021 09:30 CEST Original file -
article xml uploaded. 30 May 2021 09:30 CEST Update -
article pdf uploaded. 30 May 2021 09:30 CEST Version of Record https://www.mdpi.com/2072-6694/13/11/2694/pdf-vor
article supplementary file uploaded. 30 May 2021 09:30 CEST - https://www.mdpi.com/2072-6694/13/11/2694#supplementary
article html file updated 30 May 2021 09:31 CEST Original file -
article xml file uploaded 1 June 2021 03:23 CEST Update -
article xml uploaded. 1 June 2021 03:23 CEST Update -
article pdf uploaded. 1 June 2021 03:23 CEST Updated version of record https://www.mdpi.com/2072-6694/13/11/2694/pdf-vor
article html file updated 1 June 2021 03:25 CEST Update -
article xml file uploaded 1 June 2021 11:25 CEST Update -
article xml uploaded. 1 June 2021 11:25 CEST Update https://www.mdpi.com/2072-6694/13/11/2694/xml
article pdf uploaded. 1 June 2021 11:25 CEST Updated version of record https://www.mdpi.com/2072-6694/13/11/2694/pdf
article html file updated 1 June 2021 11:26 CEST Update -
article html file updated 26 July 2022 22:04 CEST Update https://www.mdpi.com/2072-6694/13/11/2694/html
Back to TopTop